Micro-cap New Lows: UniPixel Inc. (NASDAQ:UNXL), Mediwound (NASDAQ:MDWD), Intersections Inc. (NASDAQ:INTX), Onconova Therapeutics (NASDAQ:ONTX)

On April 3, 2014, the Company issued a press release announcing that Conductive Inkjet Technology Limited (CIT) and Uni-Pixel Displays, Inc.(NASDAQ: UNXL) have agreed to settle their on-going litigation in the U.S. and the UK. UniPixel Inc. (NASDAQ:UNXL) shares after opening at $7.92 moved to $7.99 on last trade day and at the end of the day closed at $7.50. Company price to sales ratio in past twelve months was calculated as 18.00 and price to cash ratio as 2.33. UniPixel Inc. (NASDAQ:UNXL) showed a negative weekly performance of -1.70%.

MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company developing, manufacturing and commercializing innovative therapies to address unmet needs in severe burn and wound management, on 25 march announced the closing of its initial public offering of 5,750,000 ordinary shares at a price to the public of $14.00 per share. Mediwound Ltd (NASDAQ:MDWD) shares fell -9.16% in last trading session and ended the day on $12.80. MDWD return on equity ratio is recorded as 74.90% and its return on assets is -30.80%.

On March 17, 2014, Intersections Inc. (NASDAQ:INTX) issued a press release announcing its results for the quarter and year ended December 31, 2013. Intersections Inc. (NASDAQ:INTX) shares moved down -4.02% in last trading session and was closed at $5.49, while trading in range of $5.43 – $5.84. Intersections Inc. (NASDAQ:INTX) year to date (YTD) performance is -27.28%.

Onconova Therapeutics Inc.’s (NASDAQ:ONTX) n 4 April share price has entered into oversold territory with an RSI value of 19.3. The Zacks Consensus Estimate for Onconova for the full year period has improved 75 cents over the past two months to $-2.09 per share. Onconova Therapeutics Inc. (NASDAQ:ONTX) weekly performance is -9.68%. On last trading day company shares ended up $5.69. Onconova Therapeutics Inc. (NASDAQ:ONTX) distance from 50-day simple moving average (SMA50) is -43.12%. Analysts mean target price for the company is $11.50.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *